JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome

K Kimura, T Kimura, M Ishihara, Y Nakagawa… - Circulation …, 2019 - jstage.jst.go.jp
Acute coronary syndromes (ACS) are a comprehensive disease concept characterized by
acute myocardial ischemia caused by disruption of coronary artery plaque and consequent …

ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force …

SC Smith Jr, TE Feldman, JW Hirshfeld Jr… - Journal of the American …, 2006 - Elsevier
The ACC/AHA Task Force on Practice Guidelines was formed to gather information and
make recommendations about appropriate use of technology for the diagnosis and …

Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study

J Daemen, P Wenaweser, K Tsuchida, L Abrecht… - The Lancet, 2007 - thelancet.com
Background Stent thrombosis is a safety concern associated with use of drug-eluting stents.
Little is known about occurrence of stent thrombosis more than 1 year after implantation of …

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST …

JP Bassand, CW Hamm, D Ardissino… - European heart …, 2007 - academic.oup.com
The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …

ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention—summary article: a report of the American College of Cardiology/American Heart …

WRITING COMMITTEE MEMBERS, SC Smith Jr… - Circulation, 2006 - Am Heart Assoc
that support either the 2001 recommendations that have changed or the new or revised
recommendations are cited in parentheses at the end of each recommendation or comment …

Sirolimus-eluting versus uncoated stents in acute myocardial infarction

C Spaulding, P Henry, E Teiger, K Beatt… - … England Journal of …, 2006 - Mass Medical Soc
Background Sirolimus-eluting stents reduce rates of restenosis and reintervention, as
compared with uncoated stents. Data are limited regarding the safety and efficacy of such …

Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies

R Moreno, C Fernández, R Hernández… - Journal of the American …, 2005 - jacc.org
Objectives: We compared the risk of stent thrombosis (ST) after drug-eluting stents (DES)
versus bare-metal stents (BMS), and tested the hypothesis that the risk of DES thrombosis is …

Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the “Real World” The R apamycin-E luting S tent E valuated …

PA Lemos, PW Serruys, RT van Domburg, F Saia… - Circulation, 2004 - Am Heart Assoc
Background—The effectiveness of sirolimus-eluting stents in unselected patients treated in
the daily practice is currently unknown. Methods and Results—Sirolimus-eluting stent …

Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation

ATL Ong, A Hoye, J Aoki, CAG van Mieghem… - Journal of the American …, 2005 - jacc.org
Objectives: We sought to determine the real-world incidence of angiographically confirmed
and possible stent thrombosis (ST) in an unrestricted population during the first 30 days after …

Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases

PA Lemos, F Saia, JMR Ligthart, CA Arampatzis… - Circulation, 2003 - Am Heart Assoc
Background—We describe the clinical and morphological patterns of restenosis after
sirolimus-eluting stent (SES) implantation. Methods and Results—From 121 patients with …